Interview with the scientific secretary of the 8th Gene Therapy Symposium
In the name of God, We are honored to convene specialists, researchers, professors, and students from basic and clinical sciences at the 8th Gene Therapy Symposium. This event is scheduled for December 19, 2024 (29th of Azar 1403) and will be hosted by the Pediatric Cell and Gene Therapy Research Center of Tehran University of Medical Sciences. The symposium is organized with the support of Novin Technology Mehrmam Company and will take place at the Children's Medical Center Hospital.
In recent years, advancements in medical science have demonstrated significant progress, particularly in modern treatments, leading to enhancements in healthcare services and overall public health. Within this context, gene therapy emerges as an innovative technology that offers promising therapeutic solutions for challenging diseases, including various forms of cancer and hereditary genetic disorders. Given the rapid advancements in this field and the substantial investments made by developed countries, gene therapy will soon establish itself as one of the most widely utilized and effective interventions for chronic and life-threatening conditions.
This symposium is designed to bridge the gap between basic and clinical knowledge. It will present a comprehensive program emphasizing gene therapy's core principles. It will feature the latest advancements in genome transfer and editing technologies and facilitate discussions on gene therapy applications for blood disorders and genetic diseases.
This year's symposium aims to serve as a forum for discussion among scientists and researchers involved in gene therapy. The event encourages exchanging ideas and raises awareness about the country's latest scientific advancements in this field. Participants can attend lectures by esteemed professors from national and international institutions, enhancing their knowledge and insights. Moreover, the symposium is expected to play a crucial role in elevating the status of gene therapy in the country, underscoring its vital contributions to the health system and paving the way for innovative therapeutic solutions for future generations.
Dr. Maryam Behfar
Specialist in Hematology, Oncology, and Pediatric Hematopoietic Stem Cell Transplantation
Associate Professor at Tehran University of Medical Sciences
comment